Sign In
Buy INMD
$13.21
-0.190 (-1.42%)
At Close: Jun 22, 2026
InMode Responds to Doma Perpetual's Letters
07:30am, Thursday, 06'th Mar 2025
Clarifies Capital Allocation Strategy and Commitment to Shareholder Returns Refutes Misconceptions on Staffing and Production Asserts No Justification for Additional Legal Action YOKNEAM, Israel , Mar
InMode to Present at Upcoming Investor Conferences
08:30am, Monday, 03'rd Mar 2025
YOKNEAM, Israel , March 3, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor co
InMode: Plastic Surgery Boom, Cash Flow, And Cheap
01:14am, Monday, 10'th Feb 2025
InMode is significantly undervalued, with strong cash flow, international expansion, and investments in research and marketing driving future revenue and free cash flow growth. The company benefits fr
InMode Ltd. (INMD) Q4 2024 Earnings Call Transcript
09:08am, Thursday, 06'th Feb 2025
InMode Ltd. (NASDAQ:INMD ) Q4 2024 Results Conference Call February 4, 2025 8:30 AM ET Company Participants Miri Segal - CEO, MS-IR Moshe Mizrahy - Chief Executive Officer Michael Kreindel - Chief Tec
InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program
07:00am, Tuesday, 04'th Feb 2025
Quarterly GAAP revenues of $ 97.9 million and full year revenue of $394.8 million Returned $285.4 million of capital to shareholders in full year 2024 Together with new 10% program, represents re
InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference
08:30am, Monday, 03'rd Feb 2025
YOKNEAM, Israel , Feb. 3, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will h
InMode: A Clear Bargain With Unique Risks
09:32am, Tuesday, 28'th Jan 2025
InMode Ltd. boasts superior fundamentals, yet trades at undervalued market multiples due to its unique risk profile. The company is a leader in the global aesthetics market with proprietary RF-based t
InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced
07:00am, Thursday, 16'th Jan 2025
Conference call rescheduled to Tuesday, February 4, 2025, at 8:30 a.m. Eastern Standard Time YOKNEAM, Israel, Jan. 16, 2025 /PRNewswire/ -- InMode Ltd.
DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback
08:05am, Wednesday, 15'th Jan 2025
Believes the Board Must Immediately Execute a Tender Offer for 30% of the Company Lays Out Action Plan to Restore Investor Confidence, Including an additional 10% Share Buyback in 2025 Announces Inten
InMode: Clearly, I Was Too Optimistic (Rating Downgrade)
06:07am, Friday, 10'th Jan 2025
I'm downgrading InMode from a 'Strong Buy' to a 'Buy' due to consistent guidance cuts and short-term demand issues. Despite recent performance issues and high interest rates, INMD still holds a strong
Conference call to be held on Thursday, February 6, 2025, at 8:30 a.m. Eastern Standard Time YOKNEAM, Israel, Jan. 8, 2025 /PRNewswire/ -- InMode Ltd.
InMode: Product Origination And Undervaluation Make The Stock A Buy
01:17am, Thursday, 12'th Dec 2024
InMode Ltd. demonstrates impressive net income growth from non-invasive surgical products, with new platforms Define and Envision expected to drive future business growth. The company's innovative tec
InMode to Present at Upcoming Investor Conferences
08:30am, Wednesday, 06'th Nov 2024
YOKNEAM, Israel , Nov. 6, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor con
InMode: $25/Share Is Closer Than You Think
09:43am, Tuesday, 05'th Nov 2024
Elevated interest rates continue to hurt InMode's revenue, especially as lease package interest rates haven't fallen yet. Still, future rate cuts could release pent-up demand. InMode continues to buy
InMode: A Deep Dive After Q3 Earnings
12:16pm, Thursday, 31'st Oct 2024
InMode's products are part of the medical aesthetics industry that is expected to grow at an 11% CAGR over the next five years. Despite a punishing macro environment of late that has seen its share pr
